SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001756770-23-000010
Filing Date
2023-08-10
Accepted
2023-08-09 21:11:34
Documents
10
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K q2236-kcover.htm 6-K 17087
2 EX-99.1 q223financialstatements.htm EX-99.1 1006931
3 EX-99.2 q223mda.htm EX-99.2 945543
4 EX-99.3 q223ceocertification.htm EX-99.3 9128
5 EX-99.4 q223cfocertification.htm EX-99.4 9213
6 EX-99.5 q223earningsrelease.htm EX-99.5 430019
7 EX-99.6 q223form5.htm EX-99.6 70930
8 image_0.jpg GRAPHIC 31313
9 image_013.jpg GRAPHIC 32432
10 image_0b.jpg GRAPHIC 8736
  Complete submission text file 0001756770-23-000010.txt   2590058
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 231156923
SIC: 2833 Medicinal Chemicals & Botanical Products